In the cold/allergy/sinus category, private-label products led the market with $1.476 million in annual dollar sales, while the next largest brand by share was Zyrtec with $341 million. After Zyrtec were Claritin, Alka-Seltzer Plus and Allegra with $232 million, $211 million and $209 million, respectively. While the
allergy OTC products were retail-priced between $16 and $20, Alka-Seltzer Plus came in with the thirdhighest
revenue as a cold medicine priced at $6. In the drug and food channels, allergy brands Zyrtec,
Claritin and Allegra were in the lead with $133 million, $94 million and $81 million revenue in the drug
channel (see Figure 1).

Click here for the full article.